Detalles de la búsqueda
1.
Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease.
N Engl J Med
; 373(20): 1937-46, 2015 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26559572
2.
Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial.
Am Heart J
; 173: 108-17, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26920603
3.
Extended-release niacin therapy and risk of ischemic stroke in patients with cardiovascular disease: the Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcome (AIM-HIGH) trial.
Stroke
; 44(10): 2688-93, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23881958
4.
Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial.
Am Heart J
; 166(3): 481-7, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24016497
5.
Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention.
Am Heart J
; 164(2): 243-50, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22877811
6.
Optimal medical therapy with or without PCI for stable coronary disease.
N Engl J Med
; 356(15): 1503-16, 2007 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-17387127
7.
Risk Prediction Tool for Assessing the Probability of Death or Myocardial Infarction in Patients With Stable Coronary Artery Disease.
Am J Cardiol
; 130: 1-6, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32654755
8.
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
Circulation
; 117(10): 1283-91, 2008 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-18268144
9.
Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes.
J Am Coll Cardiol
; 73(16): 2049-2058, 2019 04 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31023428
10.
Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
Circ Cardiovasc Qual Outcomes
; 11(5): e003971, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29752388
11.
Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial.
J Am Coll Cardiol
; 72(19): 2297-2305, 2018 11 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30384885
12.
The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
Am J Cardiol
; 99(2): 208-12, 2007 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17223420
13.
Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424.
Am Heart J
; 151(6): 1173-9, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16781214
14.
Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function.
J Am Coll Cardiol
; 40(10): 1735-43, 2002 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-12446055
15.
Concurrent robotic hybrid revascularization using an enhanced operative suite.
Chest
; 128(6): 4046-8, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16354880
16.
Validation of the appropriate use criteria for percutaneous coronary intervention in patients with stable coronary artery disease (from the COURAGE trial).
Am J Cardiol
; 116(2): 167-73, 2015 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25960375
17.
Validation of a three-dimensional intravascular ultrasound imaging technique to assess atherosclerotic burden: potential for improved assessment of cardiac allograft coronary artery disease.
Can J Cardiol
; 19(10): 1147-53, 2003 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-14532940
18.
Single-stage hybrid coronary revascularization with long-term follow-up.
Eur J Cardiothorac Surg
; 45(3): 438-42; discussion 442-3, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23956269
19.
Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia.
JACC Cardiovasc Interv
; 7(2): 195-201, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24440015
20.
Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart disease.
Can J Cardiol
; 30(8): 837-49, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25064578